Compare CLBK & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLBK | ARDX |
|---|---|---|
| Founded | 1927 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 996.8M |
| IPO Year | 2026 | 2014 |
| Metric | CLBK | ARDX |
|---|---|---|
| Price | $11.68 | $3.86 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $17.00 | $15.14 |
| AVG Volume (30 Days) | ★ 5.3M | 4.7M |
| Earning Date | 04-20-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | N/A | ★ $2,607,000.00 |
| Revenue This Year | $3.97 | $37.75 |
| Revenue Next Year | $11.43 | $34.24 |
| P/E Ratio | $43.67 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.51 | $3.73 |
| 52 Week High | $25.83 | $8.40 |
| Indicator | CLBK | ARDX |
|---|---|---|
| Relative Strength Index (RSI) | 35.75 | 25.38 |
| Support Level | $10.61 | N/A |
| Resistance Level | $12.00 | $6.47 |
| Average True Range (ATR) | 0.24 | 0.17 |
| MACD | 0.41 | -0.01 |
| Stochastic Oscillator | 83.73 | 3.14 |
Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a customer service-focused institution. The company offers traditional financial services to businesses and consumers in its market areas. It attracts deposits from the general public and uses those funds to originate various loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans. The company also offers title insurance through its wholly owned subsidiary and provides a broad range of insurance products, including personal and business lines of insurance, mainly to customers and New Jersey residents.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.